Major Depressive Disorder
Cybin IRL Limited focuses on clinical research in major depressive disorder, with trials centered on treatment response, symptom improvement, and sustained benefit in adult participants.
- Depression symptom management
- Therapeutic response in MDD
- Durability of antidepressant effect
The company’s research activity in this area reflects a strong interest in psychiatric disorders affecting mood and daily functioning.
Depression and Anxiety Disorders
The sponsor also shows interest in broader depression and anxiety disorders, indicating attention to overlapping mood disorder presentations and related clinical needs.
- Anxiety symptoms
- Mood and affective disorders
- Psychiatric symptom burden
This therapeutic area aligns with research aimed at improving mental health outcomes in populations with persistent affective illness.
Psychiatric Therapeutics
Cybin IRL Limited’s funded studies are concentrated in psychiatric therapeutics, with a particular emphasis on interventions intended for adult patients with depressive illness.
- Adult psychiatric treatment
- Antidepressant therapy
- Clinical outcomes in mental health
Its research portfolio is positioned within the development of new options for central nervous system disorders.
Novel Psychotropic Compounds
The sponsor is involved in research on novel psychotropic compounds, including work related to pharmacodynamics, pharmacokinetics, and safety in human subjects.
- Human safety studies
- Drug disposition and exposure
- Mechanisms of psychiatric activity
This area supports the clinical evaluation of emerging agents for mental health indications.
